Leading long COVID researcher, Akiko Iwasaki, PhD, sterling professor of immunobiology at Yale University, joins to provide an update on the latest long COVID studies and clinical trials—and what their findings mean for physicians and patients. Dr. Iwasaki discusses what we know now about the causes of long COVID, the ongoing challenges with diagnosing it and the timeline for potential treatments. American Medical Association CXO Todd Unger hosts.

🎞️ Watch Dr. Iwasaki’s previous episode here: https://youtu.be/kONtiiHsbPw?si=TMIr95DMfvuYDF3f

🔬 Distinguishing features of long COVID identified through immune profiling published in Nature: https://www.nature.com/articles/s41586-023-06651-y

📰 Scientists Offer a New Explanation for Long Covid New York Times article: https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew